From breakthrough science to globally competitive companies.
adMare’s proven model helps build investable companies that keep talent, intellectual property, investment and growth anchored in Canada.
Canada produces world-class life sciences research. And we’re good at creating companies.
But too few attract the follow-on investment they need to grow and when successful companies do scale, much of the value is captured outside Canada.
The gap isn’t simply company creation. It’s building a stronger pipeline of investable companies that keep more value in Canada and have the potential to become future anchor firms.
That’s where adMare BioInnovations comes in. Our proven model helps take companies from innovation to investable to scale.
Investable companies need:
- Validated science
- Protected intellectual property
- Experienced leadership
- Credible development and market strategies
- Access to talent, infrastructure, networks
- Investment to grow
adMare provides:
- Early-stage capital
- Industry expertise
- Intellectual property strategy
- Turnkey lab infrastructure
- Leadership development and talent support
- Investor networks
Scaling our model needs federal partnership
Pre-Budget submission
adMare is seeking $200 million in new federal investment over five years to keep translating scientific discovery into a strong pipeline of investable, Canadian-anchored life sciences companies.
A model that works
Over the last decade, adMare has worked in partnership with the federal government to help turn Canadian scientific breakthroughs into investable, high-growth life sciences companies with strong domestic foundations.
Our flexible model provides support at critical points along the early commercialization journey.
Validation
We work with Canadian researchers, providing pre-seed financing and hands-on expertise to generate data and validate the scientific and commercial potential of promising discoveries. Projects that successfully advance receive additional support to establish a company.
Incubation
We help validated companies establish strong scientific, intellectual property and domestic operating foundations, combining seed capital with scientific milestone advancement, commercialization expertise, leadership development and lab infrastructure.
Acceleration
We make milestone-based follow-on investments in high-performing companies, signalling confidence for private investors that helps attract larger financing rounds, facilitate investor syndicates and supports company growth and value-capture in Canada.
Proven results for Canada
Supported by Government contributions from 2017- 2025, adMare has invested $121 million in Canadian life sciences companies.
The results demonstrate what’s possible:
- $147M in realized returns fully re-invested, more than doubling the availability of early-stage capital.
- 3x Canadian average: success rate of adMare portfolio companies in raising significant growth capital
- $2.5B in risk capital raised from portfolio companies representing 14x private sector leverage on government-supported investment.
- Combined value of $5.8B and over 1,000 Canadian jobs created generated by adMare’s portfolio companies.
- 30+ academic partnerships creating a repeatable pathway from scientific discovery to company creation
- 2/3 adMare portfolio companies have Canadian investors, strengthening domestic value capture
- 54 Canadian life sciences companies built and scaled
Scale what’s working
Canada doesn’t need to start from scratch. adMare has a proven model that’s already working.
An investment from the federal government will help solidify and scale national capacity as the Government of Canada is seeking to accelerate made-in-Canada life sciences company creation, unlock private sector investment, and capture increased domestic economic benefit.
The result: more Canadian discoveries becoming Canadian companies, and more Canadian companies becoming globally competitive firms that create high-value jobs, domestic intellectual property and contribute to Canada’s long-term economic competitiveness, health security and resilience.
Invest in what’s working. Build more investable Canadian companies.